Oligonucleotide Manufacturing

Preclinical Development, Research-Grade

Equipped with 192-channel high-throughput synthesizers (6 units), gram-scale synthesizers (4 units), and dozens of purification devices. Annual delivery: 100,000+ HPLC-purified oligonucleotides for screening and toxicology studies.

GMP Compliance

Passed U.S. FDA cGMP on-site inspections.

Passed 10+ audits by EU, U.S., and Japanese clients.

Quality team: 23 QA + 57 QC (20% of total staff).

Strict adherence to ICH guidelines. API registrations cover China/US/EU/Japan markets.

GMP Facilities and Equipment

Filling&Lyophilization
Filling&Lyophilization
LCMS&HPLC
LCMS&HPLC
NMR
NMR
Purification
Purification
Synthesizer
Synthesizer
UV
UV

EHS System

OHSAS18000 Occupational Health and Safety Certification

Level 3 Safety Standardization Certificate for Hazardous Chemical Enterprises

2021 Sichuan Green Factory Certification

2021 Sichuan "Heavy Pollution Weather Grade B Enterprise" Certification

DCS-SIS
DCS-SIS
Exhaust Gas Treatment System
Exhaust Gas Treatment System
Wastewater Treatment System
Wastewater Treatment System
Fire Linkage Control System
Fire Linkage Control System

Collaborations

Partnered with Guangzhou Bostal to build an "API + Formulation" nucleic acid drug platform. Operational since Q4 2023, serving domestic pharma/biotech companies with 20-30% shorter project timeline.

Case Study

Double-stranded Oligonucleotide PCC-to-IND Integrated Project

With Hitston's technical support, an innovator's double-stranded oligonucleotide project achieved IND-stage delivery within 8 months (PCC to API/formulation). Seamless process development, analytical validation, and GMP production resolved complex molecular challenges, shortening timelines by 20-30% versus industry standards.

Resource Integration: Leverage parent companies' (HitGen, Easton) platforms for rapid execution.

End-to-end Capability: Cover "target screening → process development → production → IND filing" to eliminate technical gaps.

Expedited Delivery: Strict milestone control reduces timelines by 20-30%, helping clients seize market opportunities.

Thanks For Your Interest!

For more details on how we can advance your innovative drug discovery, please contact us.

* Full Name
* Email
* Phone Number
  • Angola+244
  • Afghanistan+93
  • Albania+355
  • Algeria+213
  • Andorra+376
  • Anguilla+1264
  • Antigua and Barbuda+1268
  • Argentina+54
  • Armenia+374
  • Ascension+247
  • Australia+61
  • Austria+43
  • Azerbaijan+994
  • Bahamas+1242
  • Bahrain+973
  • Bangladesh+880
  • Barbados+1246
  • Belarus+375
  • Belgium+32
  • Belize+501
  • Benin+229
  • Bermuda Is.+1441
  • Bolivia+591
  • Botswana+267
  • Brazil+55
  • Brunei+673
  • Bulgaria+359
  • Burkina+faso+226
  • Burma+95
  • Burundi+257
  • Cameroon+237
  • Canada+1
  • Cayman Is.+1345
  • Central African Republic+236
  • Chad+235
  • Chile+56
  • China+86
  • Colombia+57
  • Congo+242
  • Cook Is.+682
  • Costa Rica+506
  • Cuba+53
  • Cyprus+357
  • Czech Republic+420
  • Denmark+45
  • Djibouti+253
  • Dominica Rep.+1890
  • Ecuador+593
  • Egypt+20
  • EI Salvador+503
  • Estonia+372
  • Ethiopia+251
  • Fiji+679
  • Finland+358
  • France+33
  • French Guiana+594
  • Gabon+241
  • Gambia+220
  • Georgia+995
  • Germany+49
  • Ghana+233
  • Gibraltar+350
  • Greece+30
  • Grenada+1809
  • Guam+1671
  • Guatemala+502
  • Guinea+224
  • Guyana+592
  • Haiti+509
  • Honduras+504
  • Hongkong+852
  • Hungary+36
  • Iceland+354
  • India+91
  • Indonesia+62
  • Iran+98
  • Iraq+964
  • Ireland+353
  • Israel+972
  • Italy+39
  • Ivory Coast+225
  • Jamaica+1876
  • Japan+81
  • Jordan+962
  • Kampuchea (Cambodia )+855
  • Kazakstan+327
  • Kenya+254
  • Korea+82
  • Kuwait+965
  • Kyrgyzstan+331
  • Laos+856
  • Latvia+371
  • Lebanon+961
  • Lesotho+266
  • Liberia+231
  • Libya+218
  • Liechtenstein+423
  • Lithuania+370
  • Luxembourg+352
  • Macao+853
  • Madagascar+261
  • Malawi+265
  • Malaysia+60
  • Maldives+960
  • Mali+223
  • Malta+356
  • Mariana Is+1670
  • Martinique+596
  • Mauritius+230
  • Mexico+52
  • Moldova, Republic of+373
  • Monaco+377
  • Mongolia+976
  • Montserrat Is+1664
  • Morocco+212
  • Mozambique+258
  • Namibia+264
  • Nauru+674
  • Nepal+977
  • Netheriands Antilles+599
  • Netherlands+31
  • New Zealand+64
  • Nicaragua+505
  • Niger+227
  • Nigeria+234
  • North Korea+850
  • Norway+47
  • Oman+968
  • Pakistan+92
  • Panama+507
  • Papua New Cuinea+675
  • Paraguay+595
  • Peru+51
  • Philippines+63
  • Poland+48
  • French Polynesia+689
  • Portugal+351
  • Puerto Rico+1787
  • Qatar+974
  • Reunion+262
  • Romania+40
  • Russia+7
  • Saint Lueia+1758
  • Saint Vincent+1784
  • Samoa Eastern+684
  • Samoa Western+685
  • San Marino+378
  • Sao Tome and Principe+239
  • Saudi Arabia+966
  • Senegal+221
  • Seychelles+248
  • Sierra Leone+232
  • Singapore+65
  • Slovakia+421
  • Slovenia+386
  • Solomon Is+677
  • Somali+252
  • South Africa+27
  • Spain+34
  • Sri Lanka+94
  • St.Lucia+1758
  • St.Vincent+1784
  • Sudan+249
  • Suriname+597
  • Swaziland+268
  • Sweden+46
  • Switzerland+41
  • Syria+963
  • Taiwan+886
  • Tajikstan+992
  • Tanzania+255
  • Thailand+66
  • Togo+228
  • Tonga+676
  • Trinidad and Tobago+1809
  • Tunisia+216
  • Turkey+90
  • Turkmenistan+993
  • Uganda+256
  • Ukraine+380
  • United Arab Emirates+971
  • United Kiongdom+44
  • United States of America+1
  • Uruguay+598
  • Uzbekistan+233
  • Venezuela+58
  • Vietnam+84
  • Yemen+967
  • Yugoslavia+381
  • Zimbabwe+263
  • Zaire+243
  • Zambia+260
* Company
* Message
By submitting your information, you acknowledge having received, read and understood our Privacy Notice as made available above.